Insider Transactions in Q2 2023 at Crispr Therapeutics Ag (CRSP)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 30
2023
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
25,000
-1.55%
|
$1,625,000
$65.13 P/Share
|
|
May 30
2023
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+5.72%
|
$475,000
$19.12 P/Share
|
|
May 24
2023
|
Phuong Khanh Morrow Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,527
-36.42%
|
$164,255
$65.91 P/Share
|
|
May 23
2023
|
Phuong Khanh Morrow Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,938
+50.0%
|
-
|
|
Apr 25
2023
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
25,000
-3.06%
|
$1,250,000
$50.98 P/Share
|
|
Apr 25
2023
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+5.72%
|
$475,000
$19.12 P/Share
|